Germany· DE-A57-23d4756a288b8980
Infectocipro
A ciprofloxacin product containing ciprofloxacin hydrochloride monohydrate, registered in Germany by Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim. The same ATC class is registered in 10 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Ciprofloxacin is registered in 10 of 19 countries.
Countries holding a registration under ATC S02AA15 (ciprofloxacin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 5 of them publish a price we can compare per daily dose
Ciprofloxacin · ATC S02AA15
10 / 19 countries
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ciprofloxacin Hydrochloride Monohydrate
- Manufacturer
- Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
- Country
- Germany (DE)
- ATC code
- S02AA15
- ATC class
- Ciprofloxacin
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciprofloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCILOXANSandoz Inc
- United KingdomCetraxal 2mg/ml ear drops 0.25ml unit doseAspire Pharma Ltd
- ItalyBASEMARN.I. PHARMA S.R.L.
- SpainACEOTO 3 MG/ML GOTAS ÓTICAS EN SOLUCIÓNZambon S.A.U.
- FinlandCetraxalPOA Pharma Scandinavia AB
- SwitzerlandBactiflox 500, FilmtablettenAcino Pharma AG
- CzechiaCIFLOXINALPRO.MED.CS Praha a.s.
- BelgiumCiloxan 3 mg/gNovartis Pharma
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ciflox, Ciloxan
- Belgium · Ciloxan, Ciprofloxacine Ab
- Bulgaria · Ciprofloxacin World Medicine Europe Eood, Орпикс
- Cyprus · Cifloxacin, Ciloxan
- Czechia · Cifloxinal, Ciloxan
- Denmark · Cetraxal, Cifin
- Estonia · Ciloxan, Ciprinol
- Spain · Aceoto, Cetraflux
- Finland · Cetraxal, Ciprofloxacin Fresenius Kab
- France · Ciflox, Ciloxan
- United Kingdom (Northern Ireland) · Cetraxal, Ciloxan
- Greece · Aristin-C, Bivorilan
- Croatia · Ciflox, Ciloxan
- Hungary · Cifloxin, Cifran
- Ireland · Cifloxager, Cifox
- Iceland · Cetraxal, Ciprofloxacin Alvogen
- Italy · Basemar 250 Mg, Basemar 500 Mg
- Lithuania · Cifran, Ciloxan
- Luxembourg · Ciloxan, Ciprofloxacin Kabi
- Latvia · Cifran, Ciloxan
- Malta · Aristin-C, Cifox
- Netherlands · Cetraxal, Ciprinol
- Norway · Cetraxal, Cilox
- Poland · Cetraxal, Ciloxan
- Portugal · Cetraflux, Ciplox
- Romania · Cifran, Ciprinol
- Sweden · Cetraxal, Ciloxan
- Slovenia · Ciloxan, Ciprinol
- Slovakia · Ciphin, Ciprinol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b91b512b-4ad3-4832-a7c7-3e5fe8e71818 GET /v1/drugs/b91b512b-4ad3-4832-a7c7-3e5fe8e71818?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Auricular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ciprofloxacin Hydrochloride Monohydrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ciprofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.